Pilot Study to Investigate the Safety and Efficacy of Avelumab Monotherapy in Patients With Advanced or Metastatic Adenocarcinoma of the Small Intestine
Phase of Trial: Phase I/II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Avelumab (Primary)
- Indications Adenocarcinoma
- Focus Adverse reactions; Therapeutic Use
- 06 Mar 2017 Planned End Date changed from 1 Feb 2023 to 15 Apr 2023.
- 06 Mar 2017 Planned primary completion date changed from 1 Feb 2022 to 15 Apr 2022.
- 06 Mar 2017 Status changed from not yet recruiting to recruiting.